Peter Lebowitz
Net worth: - $ as of 30/05/2026
Net worth: - $ as of 30/05/2026
Dr. Peter F.
Lebowitz is an Independent Director at Bridgebio Oncology Therapeutics, Inc., an Independent Director at Bridgebio Oncology Therapeutics, Inc. /New/, a Chief Executive & Medical Officer, Director at Third Arc Bio, Inc. and a Head-Oncology Therapeutic Area at Janssen Research & Development LLC.
He is on the Board of Directors at Bridgebio Oncology Therapeutics, Inc., Bridgebio Oncology Therapeutics, Inc. /New/ and Third Arc Bio, Inc. Dr. Lebowitz was previously employed as a Chief Executive Officer by Aragon Pharmaceuticals, Inc.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 19/04/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 2 |
|---|---|
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions